Search research articles
Contact Us
Filters
Showing results (61-70 of 73) with videos related to
Page
of 8
Sort By:
Dementia and Geriatric Cognitive Disorders
|
November 24, 1999
A follow-up study of the family with the Swedish APP 670/671 Alzheimer's disease mutation
L O Wahlund, H Basun, O Almkvist, et al.
Annals of the New York Academy of Sciences
|
July 27, 2000
Inherited frailty. ApoE alleles determine survival after a diagnosis of heart disease or stroke at ages 85+
E H Corder, H Basun, L Fratiglioni, et al.
Neuroreport
|
May 20, 1998
EEG slowing and cerebrospinal fluid tau levels in patients with cognitive decline
V Jelic, M Blomberg, T Dierks, et al.
Neuroscience Letters
|
June 27, 1997
Cerebrospinal fluid apolipoprotein E (apoE) levels in Alzheimer's disease patients are increased at follow up and show a correlation with levels of tau protein
M Lindh, M Blomberg, M Jensen, et al.
Neuroscience Letters
|
January 22, 2000
Tau gene polymorphisms and apolipoprotein E epsilon4 may interact to increase risk for Alzheimer's disease
L Lilius, S Froelich Fabre, H Basun, et al.
Dementia and Geriatric Cognitive Disorders
|
March 25, 2010
Pittsburgh compound-B and Alzheimer's disease biomarkers in CSF, plasma and urine: An exploratory study
M Degerman Gunnarsson, M Lindau, A Wall, et al.
Archives of Neurology
|
May 1, 1997
Clinical characteristics of a chromosome 17-linked rapidly progressive familial frontotemporal dementia
H Basun, O Almkvist, K Axelman, et al.
Annals of Neurology
|
April 22, 1999
Cerebrospinal fluid A beta42 is increased early in sporadic Alzheimer's disease and declines with disease progression
M Jensen, J Schröder, M Blomberg, et al.
Journal of Internal Medicine
|
January 14, 2014
Transfer of omega-3 fatty acids across the blood-brain barrier after dietary supplementation with a docosahexaenoic acid-rich omega-3 fatty acid preparation in patients with Alzheimer's disease: the OmegAD study
Y Freund Levi, I Vedin, T Cederholm, et al.
Neurology
|
October 1, 2008
Serum cystatin C and the risk of Alzheimer disease in elderly men
J Sundelöf, J Arnlöv, E Ingelsson, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 73) with videos related to
Sort By:
Page
of 8
Dementia and Geriatric Cognitive Disorders
|
November 24, 1999
A follow-up study of the family with the Swedish APP 670/671 Alzheimer's disease mutation
L O Wahlund, H Basun, O Almkvist, et al.
Annals of the New York Academy of Sciences
|
July 27, 2000
Inherited frailty. ApoE alleles determine survival after a diagnosis of heart disease or stroke at ages 85+
E H Corder, H Basun, L Fratiglioni, et al.
Neuroreport
|
May 20, 1998
EEG slowing and cerebrospinal fluid tau levels in patients with cognitive decline
V Jelic, M Blomberg, T Dierks, et al.
Neuroscience Letters
|
June 27, 1997
Cerebrospinal fluid apolipoprotein E (apoE) levels in Alzheimer's disease patients are increased at follow up and show a correlation with levels of tau protein
M Lindh, M Blomberg, M Jensen, et al.
Neuroscience Letters
|
January 22, 2000
Tau gene polymorphisms and apolipoprotein E epsilon4 may interact to increase risk for Alzheimer's disease
L Lilius, S Froelich Fabre, H Basun, et al.
Dementia and Geriatric Cognitive Disorders
|
March 25, 2010
Pittsburgh compound-B and Alzheimer's disease biomarkers in CSF, plasma and urine: An exploratory study
M Degerman Gunnarsson, M Lindau, A Wall, et al.
Archives of Neurology
|
May 1, 1997
Clinical characteristics of a chromosome 17-linked rapidly progressive familial frontotemporal dementia
H Basun, O Almkvist, K Axelman, et al.
Annals of Neurology
|
April 22, 1999
Cerebrospinal fluid A beta42 is increased early in sporadic Alzheimer's disease and declines with disease progression
M Jensen, J Schröder, M Blomberg, et al.
Journal of Internal Medicine
|
January 14, 2014
Transfer of omega-3 fatty acids across the blood-brain barrier after dietary supplementation with a docosahexaenoic acid-rich omega-3 fatty acid preparation in patients with Alzheimer's disease: the OmegAD study
Y Freund Levi, I Vedin, T Cederholm, et al.
Neurology
|
October 1, 2008
Serum cystatin C and the risk of Alzheimer disease in elderly men
J Sundelöf, J Arnlöv, E Ingelsson, et al.
Page
of 8